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Lajos Kovács*b
5-Substituted uracils (NH2 or OH groups in position 5) have been examined theoretically and experi-
mentally as potential building blocks in quadruplex structures. Our high level Density Functional Theory
(DFT) calculations showed that the tetramer formation and stacking energies for 5-substituted uracils are
similar to the energies of purine-based xanthine (X) or guanine (G) structures. As tetrads of 5-substituted
uracils cover almost exactly the same area as purine tetrads, mixed tetrads or quadruplex structures based
on X or G and 5-substituted uracil motifs are possible. According to the calculations, 5-hydroxyuracil-
based structures are the best candidates for experimental implementation which was corroborated by the
existence of higher complexes in the mass spectra of 1-benzyl-5-hydroxyuracil. These pyrimidine-based
molecules can be used as eﬃcient building blocks in diﬀerent applications including aptamers, bio-
sensors or – taking into account the larger cavity in the central region of 5-hydroxyuracil structures – as
an artiﬁcial ion channel.
Introduction
Beyond the well-known canonical adenine–thymine (A : T) and
guanine–cytosine (G : C) base pairs in the right-handed double
helix of B-DNA, there are a plethora of other possibilities,
resulting in a large number of polymorphic variants.
Polyguanosyl-quadruplex nucleic acids (GQs) are probably the
most studied non-canonical DNA structures. A typical
G-quadruplex consists of at least two guanine G-tetrads (or
tetramers), most frequently connected by loops of one or more
nucleotides and feature various topologies.1 The stability of
the structure is based on diﬀerent components like stacking of
the tetrads, cation coordination (K+, Na+, NH4
+), hydrogen
bonding or hydrophobic eﬀects.2–4 The cations are located
either in the central cavity of the G-tetrad or in the spaces
between the stacking tetrads.
Earlier we have proved that G can be replaced by model
3-alkylxanthine derivatives (X) in tetrads/octads and the result-
ing cation-complexed tetrads and octads are comparable with
the corresponding guanine derivatives in terms of interaction
energies (for canonical numbering of purine and pyrimidine
rings cf. Fig. 1).5 Furthermore, 3-alkylxanthines undergo self-
assembly at a solid–liquid interface forming comb-like 2D
structures6 and in a bi-component system consisting of mela-
mine and 3-octadecylxanthines, porous quasi-2D networks
ensued.7
Other mimics of DNA bases can occur via oxidative damage
by exposure to both endogenous and exogenous reactive
oxygen species (ROS), which has been held responsible for a
variety of diseases (cancer, rheumatoid arthritis, and DNA
damage related to aging).8 The most abundant base-pair sub-
stitution mutation due to oxidative damage in DNA is the G : C
to A : T transition. 5-Hydroxyuracil (ho5U, aka isobarbituric
acid), produced by the oxidative deamination of cytosine, has
been established as the major chemical precursor for this
transition.8–10 The RNA analogue, 5-hydroxyuridine has been
synthesized11 and later isolated from yeast as a modified
minor RNA nucleoside.12 5-Hydroxy-2′-deoxyuridine (ho5dUrd)
has been a subject of a number of computational and experi-
mental investigations. ho5dUrd exists as a 5-hydroxy enol
tautomer forming an intramolecular hydrogen bond with the
carbonyl group in position 4 as evidenced by UV, X-ray data
and computational studies.8,13–15 It forms base pairs with all
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natural nucleobases, from which the most stable one is with
G and the least stable one is with C.8,16–18 The replacement of
base C with ho5U in the G : C base pair decreases the inter-
action energies of this base pair.19 ho5dUrd is prone to further
oxidative transformations.20,21
5-Aminouridine and its 2′-deoxy counterpart, and their N5-
acyl and N5-alkyl derivatives (glycosylated and unglycosylated)
are known to possess a wide range of biological eﬀects, includ-
ing antibacterial,22,23 antiviral,24 antifungal,25 antiprolifera-
tive26 and enzyme inhibitory activities.27–30 5-Amino-2′-deoxy-
uridine is used for high-resolution footprinting of protein–
DNA complexes.31 5-Aminouracil PNA derivatives have been
employed in redox-sensitive probes32 and in base-pairing
studies.33 It is of particular interest that 5-amino-2′-deoxyuri-
dine (n5dUrd) is a weak replacement base for thymidine in
dA : dT base pairs.34 n5dUrd, when placed in the central strand
of the DNA triple helix, recognizes all four bases A, G, C, and T
in the third strand, with a selectivity based on the orientation
(parallel/antiparallel) of the third strand.35–38 Only very
recently Galeone et al. demonstrated experimentally the exist-
ence of a quadruplex structure in guanine-rich oligonucleo-
tides containing a single 5-aminouracil tetrad39 but a detailed
theoretical analysis is still missing concerning the binding
character of the new complex.
As, to the best of our knowledge, there is no detailed inves-
tigation directed towards the application of 5-substituted
uracil derivatives in quadruplex research, our aim was to care-
fully analyze the properties of the quadruplexes containing
these interesting compounds. More specifically, we were intri-
gued whether and how the “truncation” of the purine ring at
the imidazole moiety of X (removing atoms C-8 and N-9)
aﬀects the tetrad-/quadruplex-forming potential (Fig. 1; the
notation hz5U was chosen for 5-substituted uracils to harmo-
nize with the current IUPAC nomenclature recommendations
on the designation of substituents in nucleobases.40 For the
sake of simplicity, the abbreviations hz5U, n5U, and ho5U
denote 5-substituted uracil, 5-aminouracil and 5-hydroxyuracil
derivatives, respectively, regardless of the nature of the substi-
tuent in position 1). Therefore, 1,5-disubstituted uracils, con-
taining amino or hydroxy groups in position 5 and a methyl or
a benzyl group in position 1, have been considered in our
present computational and experimental studies and scruti-
nized for their capability to form hydrogen bonds in the sup-
posed supramolecular assemblies.
The present work will highlight the quadruplex-forming
ability of single-ring based artificial nucleobases motivated
by our previous 3-methylxanthine (X) study.5 The new candi-
dates were derived by theoretical considerations using high
level DFT calculations followed by mass-spectrometric experi-
ments demonstrating the relevance of our computational
investigations.
Results and discussion
Derivation of the building blocks and the applied
computational method
Prior to experimental work, computational simulations have
been performed to forecast the self-assembling possibilities of
the new molecules based on our former 3-methylxanthine (X)
investigation.5 The theoretical consideration behind selecting
the candidates is demonstrated in Fig. 1, where the area
shaded in grey indicates the part of xanthine that is not
involved directly in the formation of a tetrad/quadruplex.
The simplest modification in which the above-mentioned
part is truncated from the original xanthine led us to 5-substi-
tuted uracil (hz5U) derivatives where ZH = NH2 or OH (Fig. 1).
The new single-ring molecules preserve the original donor/
acceptor hydrogen bond pattern, therefore we expected similar
Fig. 1 The hydrogen-bound tetrameric structures of 3-methylxanthine
(X) [panel (a), the monomer is in dashed bold rectangle] and the result
of the truncation (area shaded in grey); tetrameric assemblies of 5-sub-
stituted 1-methyluracils (hz5U) [panel (b), the monomer is in dashed
bold circle, where ZH = NH2 or OH]. The hydrogen bonds connecting
the tetrameric structures are represented by hashed lines, the abbrevi-
ation “cat+” may represent cations. Schematic representations of X and
hz5U, along with their canonical numbering, are outlined at the right-
bottom part of the structures.
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tetramer-forming abilities. Additionally, they can form not
only pure hz5U homo-tetramers but can also provide hetero-
tetramers with the original xanthine molecule.
In the computational simulations a gradual protocol was
followed in all cases, where the candidates were examined and
compared to the original xanthine complexes in various dimer
(D), tetramer (T) and octamer (O) geometries (Scheme 1). For
the sake of simplicity, not all the possible combinations of the
5-substituted uracil derivatives have been considered, only the
homomeric complexes and the heteromeric complexes with X
units were examined computationally.
All calculations were performed with the ADF program suit
at the BLYP-D3/TZ2P level of theory. The detailed description
and references of the applied techniques and programs can be
found in the Experimental part, as well as the basics of the
energy decomposition analysis method (EDA).
The case of 5-amino-1-methyluracil
Having completed the first step in the theoretical part, the
simplest derivative of the truncated X molecule was considered
as 5-amino-1-methyluracil (n5U, cf. Fig. 1) where the broken
bonds in the truncated part (cf. Fig. 1a, grey area) were capped
by hydrogens. Although the quadruplex-forming ability of this
compound was demonstrated experimentally39 very recently as
a part of a G-rich oligonucleotide chain, a high level compu-
tational analysis was completely absent which could provide a
more detailed insight into the energetic character of the new
tetramer structure. However, it is also necessary to be able to
compare the tetramer-forming ability of the n5U-based tetrad
to the other (e.g. G- or X-based) ones without the support of
four additional embracing G4 layers in a heptanucleotide oligo-
mer [d(TGGn5UGGT)]4 which was not investigated in the men-
tioned study.39 Moreover, the reference nucleosides (thymidine
and 5-bromo-2′-deoxyuridine) used in that study contained
methyl and bromo substituents in position 5 which seem not
relevant because these groups cannot form hydrogen bonds.
Beside that fact, it was also not investigated how these electron
donating and withdrawing groups (methyl and bromo, respect-
ively) can aﬀect the lactam–lactim tautomeric equilibrium in
the pyrimidine ring which can highly aﬀect the hydrogen bond
pattern.
Thus, in our examinations, first we investigated the n5U
derivative computationally and compared the results to the X
complexes as our reference point. We have considered all poss-
ible dimer geometries obtained from tetramers and optimized
them. The minimized structures, as well as their interaction
energies are presented in Fig. 2.
It is obvious from Fig. 2 that the new molecule has a con-
siderably weaker interaction with another similar molecule
(D4 in Fig. 2) and the optimum dimer geometries are also less
planar compared to the original X2 dimer (D1 in Fig. 2).
Assuming that there is no other eﬀect beyond the neighboring
n5U pair interactions, the (n5U)4 unit was expected to be a less
stable tetramer complex and the original X-based one would
be the most stable one. Indeed, comparing the interaction
energies of (n5U)4 and X4 tetramers, the new structure
showed almost 25 kcal mol−1 weaker interaction energy
(−49.0 kcal mol−1 and −73.6 kcal mol−1, respectively) than the
latter one. As the tetramer-forming ability of the (n5U)4 mole-
cule is worse than that of X4 the formation of an (n
5U)4 tetrad
without embracing G4 layers is less feasible compared to X4.
However, the results raised the question, why has n5U such
a diﬀerent tetrameric interaction energy while it still has the
same hydrogen bond pattern as X? First, it is important to
notice in Fig. 2 that the interaction energy is always weaker
Scheme 1 Schematic summary of the computationally investigated
complexes in the present study. For simplicity, hereafter in tables and
ﬁgures we will refer to the abbreviations D1–D4, T1–T4, O1–O9 intro-
duced here.
Fig. 2 Optimum hydrogen bonds with heteroatom distances (in Å) and
the interaction energies (in kcal mol−1) of the X and n5U complexes
D1–D4. See also Scheme 1 for the schematic representation of the
dimers. Xanthine molecules are designated with X.
Organic & Biomolecular Chemistry Paper
This journal is © The Royal Society of Chemistry 2017 Org. Biomol. Chem.
Pu
bl
ish
ed
 o
n 
20
 D
ec
em
be
r 2
01
6.
 D
ow
nl
oa
de
d 
by
 U
N
IV
ER
SI
TY
 O
F 
SZ
EG
ED
 o
n 
06
/0
1/
20
17
 1
4:
54
:4
7.
 
View Article Online
when the amino group is involved in the hydrogen bonds (see
Fig. 2, D2 and D4). In Table 1 we present the results of energy
decomposition analysis (EDA) regarding the possible dimers
and the two homo-tetramer calculations. In the dimer cases we
did not apply any symmetrical restraint but for tetramers the
planar restraint was used to mimic a possible G4 environment
or the presence of a surface. This planar restraint causes less
than 1 kcal mol−1 energy diﬀerence between the optimum in
C4h or C4 symmetry for both systems.
Previous analyses41–45 showed that hydrogen bonds
between nucleobases or derivatives thereof have a substantial
covalent character as it can be seen from the significant orbital
interaction component (ΔEoi) in the EDA. Table 1 shows
clearly that in our systems the term ΔEoi contributes around
35% of the attractive interactions which is in the same order of
magnitude as the electrostatic component providing the
remaining attraction together with the small dispersion term.
This significant orbital interaction physically manifests in a
charge transfer between an unoccupied σN–H* orbital of the
proton-donor fragment and the lone pair on nitrogen or
oxygen of the proton-acceptor constituent. In a clear σ–π separ-
ation (planar symmetry) the interacting orbitals are usually the
σLUMO and σHOMO orbitals of the two monomers, and the
strength of the orbital interaction is proportional to the over-
lapping integral and inversely proportional to the orbital
energy diﬀerence between the electron donor and acceptor
orbitals (see e.g. ref. 46).
The frontier orbitals, which significantly take part in the
formation of hydrogen bonds, are presented in Fig. 3 for all
three molecules examined in the present study. Considering
the electron donation part of the bond formation, we found
that the σHOMO and the σHOMO−1 are the most important orbi-
tals. For the n5U molecule the free optimization does not
support perfect σ–π separation due to the pyramidalization of
the amino group but when planar restraints were applied, the
interacting electron-donor orbitals were also the σHOMO and
the σHOMO−1 ones. Comparing the corresponding σHOMO and
σHOMO−1 orbitals of X and n5U monomers, they were found to
be very similar regarding the orbital energies or distributions.
Hence, these orbitals cannot induce any larger changes in the
interaction energies via the orbital interaction term.
Considering the electron-acceptor orbitals in the hydrogen
bonds, which are the σLUMO and σLUMO+1 in the original
X case, the corresponding σLUMO has a completely diﬀerent
distribution at the amino group (cf. Fig. 3). More precisely, the
σLUMO is localized mainly between the methyl and the amino
groups, and according to the orbital distribution, the σLUMO+1
and σLUMO+2 orbitals can play the same role in the n5U mole-
cule as the σLUMO and σLUMO+1 orbitals in the original X one.
However, this fact means a shift in the orbital energies which
enlarge the denominator in the orbital energy interaction, as
we described hereinabove. Thus, the orbital interaction is
weakening and consequently, the total interaction as well.
Taking into account that the distributions of the σHOMO and
σHOMO−1 orbitals are very similar for both molecules, in the
next step we aimed at changing the σLUMO part of the
molecule.
According to Fig. 3, the main problem regarding the weaker
interaction of the new molecule is that the capping hydrogen
in the amino group of the truncated X molecule localizes the
σLUMO as well as the σLUMO+1 to the non-bonding part of the
n5U molecule. Moreover, the analogue of the σLUMO+1 of X is
also shifted with one level higher in n5U which is also weaken-
ing the orbital interaction energy. Concerning the EDA, it
means smaller absolute value for each term but the change in
the attractive terms (ΔVelstat, ΔEoi) altogether are larger than in
the repulsive one (ΔEPauli). Thus, we aimed at redirecting the
LUMO orbital distribution to the interacting region in a new
molecule. The simplest solution to provide a more directed
electron-acceptor LUMO orbital is the substitution of the
amino group by a hydroxy group in position 5. According to
our expectation this modification (n5U→ ho5U) can strengthen
the total interaction energy via a better orbital interaction
term. Furthermore, the complex of the new molecule can be
more planar because of the flexibility of the hydroxy group
which is beneficial in the tetramer formation.
Table 1 EDA energy terms (in kcal mol−1) of X and n5U dimer com-
plexes optimized without constraint (nosym case) and the planarly
restricted (C4h case) homotetramers of the two units
X2
(D1)a
(n5U)2
(D4)
X–n5U
(D3)
X–n5U
(D2)
X4
(T1)
(n5U)4
(T4)
ΔEint −18.6 −12.5 −19.1 −12.4 −73.0 −51.0
ΔEPauli 29.6 20.7 30.6 21.5 121.9 85.4
ΔVelstat −26.0 −18.2 −26.7 −18.2 −102.7 −74.9
ΔEoi −18.0 −11.0 −18.7 −11.3 −74.6 −46.4
ΔEdisp −4.1 −3.9 −4.2 −4.4 −17.6 −15.1
a For the definition of geometries D1–D4, T1 and T4 see Scheme 1.
Fig. 3 Frontier σ orbitals with orbital energy (in eV) regarding the quad-
ruplex formation. Geometries are taken from optimized monomers with
planar restraint and the arrows in the ﬁrst column show the direction of
the electron donation in the hydrogen bonds.
Paper Organic & Biomolecular Chemistry
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The case of 5-hydroxy-1-methyluracil
As we pointed out in the previous section, the truncation of
the non-interacting part of the X molecule led to a weaker
tetrameric structure. Focusing onto the important frontier
orbitals in the interaction, the analysis allowed us to identify
5-hydroxy-1-methyluracil (ho5U) as a pyrimidine derivative
with promising tetramer forming ability. By inspecting the
frontier orbitals in the ho5U monomer molecule (bottom row
in Fig. 3), it is clear that the amino to hydroxy substitution did
not alter the σHOMO and σHOMO−1 distributions, it only shifted
the energies by 0.4 eV. Considering the σLUMO, σLUMO+1 and
σLUMO+2 orbitals, there are larger changes. Although the substi-
tution cannot heal the problem of the σLUMO distribution, in
the σLUMO+1 case there are significant changes regarding the
orbital distribution. Namely, one can see a noteworthy orbital
lobe around the OH group, which points toward the requested
direction. Very similar orbital redistribution appeared in the
σLUMO+2 case which renders the ho5U molecule a promising
candidate.
Following the hierarchy of the computational investi-
gations, first we examined those dimer interactions which take
part in the formation of the tetramers. In Fig. 4 we summar-
ized them similarly to Fig. 2, where all the relevant homo- and
hetero-dimer connections are considered. One of the striking
features of these calculations is the nice planarity of the opti-
mized structures. This is the simple consequence of the fact
that there are no pyramidalization eﬀects in the ho5U com-
plexes which would enforce the non-planar geometry of the
fragments. This can help the formation of tetramer structures,
as well as the incorporation into other quadruplex structures
(e.g. G4 or X4). The other important result is that the inter-
action energies significantly improved, and the D3 mixed
complex in Fig. 4 has the largest interaction energy out of all
dimer interactions considered in this paper.
In Table 2 the EDA terms of all three homo-dimers
[X2, (n
5U)2, (ho
5U)2] have been compared. We found that
always the X2 dimer has the largest value in absolute sense but
the (ho5U)2 energy terms are much closer to the X2 results
than to the (n5U)2 ones. We would like to highlight that these
orbital interaction energy values corroborate our expectation
regarding the better frontier orbital interactions in the X2 and
(ho5U)2 cases with respect to the dimer (n
5U)2.
After the investigation of the tetramer-forming ability of the
ho5U candidate, we calculated all the tetrads which are men-
tioned in Scheme 1. In Table 3 the interaction energies as well
as the corresponding EDA terms have been summarized.
It is obvious from Table 3 that both mixed tetrameric struc-
tures provide approximately 10% larger interaction energy
than the pure (ho5U)4 tetramer. This is in line with our experi-
ments where the formation of the mixed tetramers is more
common. The clear σ–π separation (planar restraint) reveals
that the σ electronic system has a principal role in the
formation of the tetramers, as it yields the vast majority of the
orbital interaction term. In summary we can say that the inter-
action character of these tetrameric structures could be pre-
dicted accurately from the previous molecular orbital analysis
based on monomer and dimer complexes.
Finally, we would like to highlight certain geometrical
aspects of the optimized tetramers. In Fig. 5 the optimized
geometries of the planar (ho5U)4 and X4 structures are shown,
and the diagonal distances between two oxygen atoms (con-
nected to the C(6) atom), as well as the distance between the
methyl groups of two adjacent units are presented. Taking into
account the four-fold symmetry of the systems, it is obvious
that the two complexes cover almost exactly the same area.
Considering the connection points to the sugar phosphate
backbone (represented by the methyl groups), Fig. 5 exhibits
clearly that the distances between the backbones are almost
exactly the same. Thus, it can be expected that the new deriva-
tives can be easily incorporated into quadruplex structures
based on X or G tetramers. This is the consequence of the
similar methyl-group distances, due to the fact that when real
Fig. 4 Optimized dimer geometries of ho5U complexes with optimum
distances (in Å) and their interaction energies (in kcal mol−1). Xanthine
molecules are designated with X.
Table 2 Total interaction energies (ΔEint) and the EDA terms (in kcal
mol−1) for all three homodimers
X2 (D1)
a (n5U)2 (D4) (ho
5U)2 (D4)
ΔEint −18.6 −12.5 −16.6
ΔEPauli 29.6 20.7 28.4
ΔVelstat −26.0 −18.2 −24.4
ΔEoi −18.0 −11.0 −16.7
ΔEdisp −4.1 −3.9 −3.9
a For the definition of geometries D1 and D4 see Scheme 1.
Table 3 Total interaction energies (ΔEint) with respect to the mono-
mers and the results of the EDA (in kcal mol−1) for ho5U- and X-based
tetramers. All geometries were optimized in planar symmetry
Tetramers
(geometries)a
(ho5U)2 + X2
(T2 geom.)
(ho5U)2 + X2
(T3 geom.)
(ho5U)4
(T4 geom.)
ΔEint −66.0 −66.2 −60.8
ΔEPauli 113.4 114.8 105.1
ΔVelstat −95.8 −96.5 −89.3
ΔEoi −67.5 −68.3 −61.6
ΔEoi(σ) −60.7 −61.4 −55.7
ΔEoi(π) −6.8 −6.9 −5.9
ΔEdisp −16.1 −16.2 −14.9
a For the definition of geometries T2, T3 and T4 see Scheme 1.
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sugar-phosphate spines are connected in that position, this
backbone does not have to be distorted to adopt the optimum
geometry. The cluster formation of ho5U (see mass spectro-
metric evidence later) convincingly supports our compu-
tational results.
The second important consequence of the present tetramer
geometry is that the central cavity in the ho5U complex has
some 15% (0.7 Å) larger diameter than the X4 one (Fig. 5). It
provides space for larger cations in the center region, as well
as it can alter the ion mobility character of the central
channel, which could be important for the design of new
quadruplex-based artificial ion channels.47–51
Octamer structures and ion binding
The final step in the theoretical part was the investigation of
the stacking of tetrads. It is important to note that the pres-
ence of a cation (Na+, K+, NH4
+) in the central channel of quad-
ruplexes is essential as it stabilizes the quadruplex formation.
Thus, beyond the stacking possibilities, the ion-binding abil-
ities were also examined. The simplest stacked geometry is the
octamer structure with two tetramer layers where the tetramers
are positioned above each other with or without the cation in
the central cavity of the complex. Obviously, the stacking inter-
action plays an important role in the formation of an octamer
by stabilizing the connection between adjacent layers,52–54 but
the eﬀect of the central cation (when present) is also impor-
tant. To distinguish the eﬀect of these two interactions, we
examined the “empty” octamers and the octamers with cations
separately.
The stacking possibility of the new candidates was investi-
gated in the first step in homo-octamers where all the building
blocks were identical in the structure. According to Scheme 1,
this is the O1 case for the original X molecule and the O2
arrangement for the n5U or ho5U derivatives, respectively.
Following the geometrical optimization, we determined the
interaction energies between the two layers, and the results
were −53.0 kcal mol−1, −48.4 kcal mol−1 and −51.4 kcal mol−1
for the X8, (n
5U)8 and (ho
5U)8 structures, respectively. These
numbers clearly illustrate that the stacking interaction is
almost the same for the old and the new systems. This is in
contrast to our expectation as we supposed that the purine-
based octamer will have considerably larger stacking inter-
action. Moreover, the stacking energy between two diﬀerent
homo-tetramers (O3 in Scheme 1) was found to be −51.5
kcal mol−1 for the (ho5U)4 + X4 complex which forecasts a
promising quadruplex-forming ability for the new building
block in combination with purine-based quadruplex struc-
tures. This character of the n5U tetrads was experimentally
proven by Galeone et al. in a recent paper39 showing that the
n5U bases form a tetramer structure between the guanine
layers of oligonucleotide [d(TGGn5UGGT)]4.
Calculating the mixed octamer structures (cf. O4–O9 in
Scheme 1) for the ho5U and X complexes we found that the
stacking energy was always around −50 kcal mol−1 (see
Table SI-1 in the ESI†). This fact indicates that almost any com-
bination of the new candidate ho5U with the X molecule is
conceivable which is very useful in the design of new aptamers
or bio-sensors.
The last part in the computational investigation of the new
molecules was the cation binding analysis of the systems. At
the end of the previous section we highlighted the importance
of the size of the cavity in the center of the tetramer structure.
It is well known that cations can bind to this region in quadru-
plex structures and ion coordination can greatly contribute to
the formation of quadruplex structures.52–54 The optimized
structures of X8 and (ho
5U)8 quadruplexes with ammonium
cation are presented in Fig. 6 (top and side views). We would
like to note that during the optimization we did not require
planar symmetry for the tetramer layers, however, the side
views indicate that the layers kept the planar geometry quite
well. The interaction energies between the NH4
+ ion and the
octamer structures were found to be −105.6 kcal mol−1 and
−104.1 kcal mol−1 for the clusters [X8 + NH4]+ and [(ho5U)8 +
NH4]
+ respectively. Similar small diﬀerences were calculated
in the presence of Na+, namely −126.3 kcal mol−1 and
−125.0 kcal mol−1 interaction energies for the clusters
[X8 + Na]
+ and [(ho5U)8 + Na]
+, respectively, while there was
almost no diﬀerence in the case of the K+ ion (Eint[X8 + K]
+ =
−104.2 kcal mol−1 and Eint[(ho5U)8 + K]+ = −104.8 kcal mol−1).
These values are in line with our previous results.4
Fig. 5 Optimized planar tetramer structures of X4 (left) and (ho
5U)4
(right) complexes with selected distances (in Å).
Fig. 6 Optimized X8 (left) and (ho
5U)8 octamers (right) with the NH4
+
cation in the central position.
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Nevertheless, it would be interesting to calculate the ion mobi-
lity of larger quadruplex structures, but this investigation is
beyond the scope of the present work.
An additional diﬀerence between the original and the new
quadruplex systems was found in relation to the optimal rela-
tive twist of adjacent layers. Explicitly, the twist angle of the
two layers was always larger in the (ho5U)8 case than in the X8
complex, independently from the presence or absence of a
cation. However, we would like to emphasize the shallow char-
acter of the minima regarding the twist angle. For example,
rotating the two layers (without relaxation) with +5 and
−5 degrees in the (ho5U)8 case provides only 0.8 and 1.2
kcal mol−1 change in the total energy, respectively. Although
in the NH4
+ case the orientation of the hydrogens can strongly
influence the relative orientation of the layers, in the less
directed [X8 + K]
+ complex the twist angle of the optimized
structure was 21.8° while the same angle was 44.1° in the
[(ho5U)8 + K]
+ system. This latter value means that an almost
perfect staggered conformation is present in this complex.
According to ref. 55 the twist angle was found larger than 40°
for G-quadruplexes only in a special quadruplex backbone
topology. But taking into account the shallow character of the
energy minimum regarding the twist angle, the backbone can
easily bridge the diﬀerence between the two optima.
ESI-MS analyses of cluster formation of 5-amino- and
5-hydroxyuracil derivatives
In our previous work the experimental method which indi-
cated the existence of tetrameric structures in the gas phase
was the ESI-MS technique.5 Therefore, 1-methyl- and 1-benzyl-
uracil derivatives have been investigated with the ESI-MS tech-
nique to observe the presence of the tetrameric complexes.
The benzyl derivative of 5-hydroxyuracil was chosen for the
sake of simplicity as methylation of the starting 5-bromouracil
gave poor yields and mixtures that were diﬃcult to purify.56
The ESI mass spectrum of 5-amino-1-methyluracil did not
reveal the presence of higher-order structures, only simple
adducts ([M + cat]+, cat = H, NH4, Na) could be observed. To
ascertain whether 5-amino-1-methyluracil exhibits the propen-
sity of replacing 3-methylxanthine in tetrads/octads, 5-amino-
1-methyluracil has been mixed with 3-methylxanthine and the
mass spectrum of this mixture was recorded. Indeed, low-
intensity mixed dimers and trimers containing one 5-amino-1-
methyluracil and ammonium ion (omnipresent in mass
spectrometers) could be detected even without added salts but
no other clusters could be observed (Fig. 7). Purposefully
added ammonium salts did not alter this situation.
The mass spectra of 1-benzyl-5-hydroxyuracil (ho5U, M =
218) in the absence of added salts showed protonated mono-
meric ([M + H]+) and dimeric ([2M + H]+) species but no
higher-order clusters could be observed. Upon the addition of
ammonium salts into aqueous solutions of methanol or
1,1,1,3,3,3-hexafluoroisopropanol (HFIP) a series of low-inten-
sity ammonium adducts with 2, 3, 4, 5, 8 and 12 uracil
moieties appeared (Fig. 8). We have noted that increasing the
concentration of HFIP enhanced the signal-to-noise ratio and/
or stabilized the clusters.
The separation of overlapping isobaric singly and doubly
charged species ([6M + NH4]
+ and [12M + 2NH4]
2+, m/z = 1327
for both entities) could be achieved using electrospray ioniza-
tion field asymmetric waveform ion mobility mass spectro-
metry combined with mass spectrometry (ESI-FAIMS-MS).57
This is a special MS technique requiring sophisticated instru-
mentation. Fortunately, in our case this separation could be
simply attained by analyzing the isotopic distribution of the
high resolution mass spectrum (Fig. 9) which unequivocally
confirmed that the peaks around m/z = 1327 originate from
the doubly charged dodecameric species [12M + 2NH4]
2+
which is very likely a triple-layered quadruplex structure (mul-
tiple charged sodiated complexes of 3-methylxanthine (X) with
Fig. 8 ESI-MS spectrum of 1-benzyl-5-hydroxyuracil (ho5U, M = 218) in
the presence of ammonium hydrogen carbonate in HFIP.
Fig. 7 Mixed ESI-MS spectrum of 5-amino-1-methyluracil (n5U; M =
141) and 3-methylxanthine (X; M = 166) without added salt.
Fig. 9 Isotopic distribution of the peak [12M + 2NH4]
2+ of 1-benzyl-5-
hydroxyuracil (ho5U, M = 218.20870) (high resolution mass spectrum).
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up to 32 units, e.g. [(X4)8 + 6Na − 3H]3+, have been previously
reported57).
The experimental finding that in the mass spectra of
1-benzyl-5-hydroxyuracil, tetra-, octa- and dodecameric species
appeared only upon addition of ammonium salts invalidates
the assumption that eventual stacking interactions exerted by
the benzyl side groups would significantly contribute to the
stability of the above clusters. Instead, hydrogen bonding, gov-
erned by ion coordination is the principal stabilizing factor in
cluster formation of ho5U derivatives. The quantum mechan-
ical calculations of Marek et al.52–54 underscore that stacking
between nucleobases plays a subordinate role in stabilizing
ion-bound clusters: stacking provides 10% of the formation
energies in vacuo for guanine octamers [(G4)2 + cat]
+ (cat = Na,
K), 12–14% for xanthine octamers [(X4)2 + cat]
+ (cat = Na, K),
12–14% for guanine dodecamers [(G4)3 + 2cat]
2+ (cat = Na, K)
and 19–21% for xanthine dodecamers [(X4)3 + 2cat]
2+ (cat = Na,
K) as deduced from the energy decomposition analyses53 (in
water the stacking term is slightly higher, especially for
xanthine).52,54
A series of adduct-forming salts (NH4
+, Na+, K+, Ca2+, Sr2+
and Ba2+ cations) have also been tested with ho5U and various
adducts have been detected (e.g. [8M + cat]2+, cat = Ca, Sr) but
NH4
+ formed the most intensive complexes, e.g. [4M + NH4]
+
(ESI, Fig. SI-9†). The ESI-MS spectrum of a mixture containing
1-benzyl-5-hydroxyuracil and 3-methylxanthine has also been
recorded and the replacement of one or two 3-methylxanthine
moieties by 1-benzyl-5-hydroxyuracil could be observed in
tetrads and octads (Fig. 10). The experimentally found
X : ho5U = 3 : 1 and 7 : 1 stoichiometries in these clusters pre-
viously have not been calculated but as it was pointed out
earlier, almost any combination of ho5U with the X moiety is
conceivable owing to the very similar tetrad-/octad-forming
character of X and ho5U bases.
These observations are in good correlation with the compu-
tational predictions, viz., (1) 5-aminouracil derivatives form
weak clusters, while (2) 5-hydroxyuracil-containing clusters
are comparable in stability with those formed from
3-methylxanthine.
Experimental
Computational methods
All calculations were performed with the Amsterdam Density
Functional (ADF) program58–68 and QUILD69,70 using dis-
persion-corrected relativistic density functional theory at the
BLYP-D3/TZ2P71–75 level for geometry optimizations and ener-
gies. The overall bond energy ΔEbond is made up of two major
components:
ΔEbond ¼ ΔEprep þ ΔEint ð1Þ
In this formula, the preparation energy ΔEprep is the
amount of energy required to deform the separate bases from
their equilibrium structure to the geometry that they acquire
in the tetrad. The interaction energy ΔEint corresponds to the
actual energy change when the prepared bases are combined
to form the tetrad.
The interaction energy is examined in the framework of the
Kohn–Sham MO model using a quantitative energy decompo-
sition analysis (EDA) into electrostatic interactions, Pauli repul-
sive orbital interactions, and attractive orbital interactions, to
which a term ΔEdisp is added to account for the dispersion
interactions:76
ΔEint ¼ ΔVelstat þ ΔEPauli þ ΔEoi þ ΔEdisp ð2Þ
The term ΔVelstat corresponds to the classical electrostatic
interactions between the unperturbed charge distributions of
the prepared (i.e. deformed) bases and is usually attractive.
The Pauli repulsion ΔEPauli comprises the destabilizing inter-
actions between occupied orbitals and is responsible for any
steric repulsion. The orbital interaction ΔEoi accounts for
charge transfer (i.e., donor–acceptor interactions between
occupied orbitals on one moiety and unoccupied orbitals on
the other, including the HOMO–LUMO interactions) and
polarization (empty–occupied orbital mixing on one fragment
due to the presence of another fragment).
The orbital interaction energy can be further decomposed
into the contributions from each irreducible representation Γ
of the interacting system (eqn (3)) using the extended tran-
sition state (ETS) scheme developed by Ziegler and Rauk.77–79
In planar systems, the symmetry partitioning allows us to dis-
tinguish σ and π interactions:
ΔEoi ¼ ΔEoiðσÞ þ ΔEoiðπÞ ð3Þ
Synthesis
Unless otherwise noted, solvents and reagents were reagent
grade from commercial suppliers and used without further
purification. 5-Amino-1-methyluracil80,81 has been purchased
from ZereneX Molecular (UK). 5-Bromouracil has been syn-
thesized from uracil according to a published method.82 All
Fig. 10 Mixed ESI-MS spectrum of 1-benzyl-5-hydroxyuracil (ho5U,
M = 218) and 3-methylxanthine (X, M = 166) without added salt. The
exact composition of peaks at m/z 1014 and 1019 (whether they rep-
resent the clusters [6X + NH4]
+ or [12X + 2NH4]
2+) and [6X + Na]+ or
[12X + 2Na]2+, respectively) was not investigated in detail.
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moisture-sensitive reactions were performed under an argon
atmosphere using oven-dried glassware. Reactions were moni-
tored by TLC on Kieselgel 60 F254 plates (Merck) with detection
by UV. Flash column chromatography was carried out using
silica gel (particle size 40–63 μm). Melting points (uncor-
rected): Electrothermal IA 8103 apparatus. Elementary ana-
lyses: Perkin-Elmer CHN analyzer model 2400. 1H and
13C NMR spectra were recorded in DMSO-d6 using a Bruker
Avance DRX 500 instrument and assignments are based on
J-modulated spin-echo experiments. ESI-MS analyses were per-
formed on a Waters Acquity SQD mass spectrometer (positive
ionization mode) and the high resolution spectra were
recorded on a Thermo Fisher Scientific Q Exactive™ Plus
Hybrid Quadrupole-Orbitrap™ Mass Spectrometer (positive
ionization mode).
Benzylation of 5-bromouracil. 5-Bromouracil (2.00 g,
10.47 mmol) was dissolved in anhydrous DMF (40 mL) under
sonication. Anhydrous K2CO3 was added (1.446 g, 10.46 mmol,
1.0 equiv.) and the heterogeneous solution was stirred at room
temperature for 15 min. The obtained potassium salt was
treated dropwise with benzyl bromide (1.306 mL,
10.996 mmol, 1.05 equiv.) and the reaction mixture was stirred
at room temperature for 22 h. The heterogeneous solution was
acidified with acetic acid, evaporated in vacuo and co-evapor-
ated with CH3CN (2×). The residue was dissolved in water
(50 mL) and extracted with EtOAc (3 × 75 mL). The combined
organic layers were dried (MgSO4), filtered and evaporated
in vacuo. The crude product was purified by column chromato-
graphy using the solvent system 3–5 v/v% isopropanol in
toluene to give 1-benzyl-5-bromouracil (1.211 g, 41.1%) and
1,3-dibenzyl-5-bromouracil (1.312 g, 33.8%).
1-Benzyl-5-bromouracil. An analytical sample has been
obtained from the previously purified title compound by
recrystallisation from isopropanol. Mp.: 209.7–210.6 °C.
ESI-MS (m/z): 281.0 (100, [(79Br)M + H]+), 283.0 (95, [(81Br)M +
H]+). 1H NMR (δ, ppm): 4.84 (s, 2 H, CH2), 7.05–7.48 (m, 5 H,
arom.), 8.30 (s, 1 H, H-6), 11.81 (br. s, deuterable, 1 H, NH).
13C NMR (δ, ppm): 50.8 (CH2), 95.2 (C-5), 127.5, 127.8, 128.7
(arom. CHs), 136.5 (C-1′), 145.2 (C-6), 150.4 (C-2), 159.7 (C-4).
Elemental analysis calcd (%) for C11H9BrN2O2 (281.105) C,
47.00; H, 3.23; Br, 28.42; N, 9.97, found C, 47.18; H, 3.40; Br,
28.63; N, 9.81.
1,3-Dibenzyl-5-bromouracil. An analytical sample has been
obtained from the previously purified title compound by
recrystallisation from isopropanol. Mp.: 123.0–125.5 °C (dec.).
ESI-MS (m/z): 371.1 (100, [(79Br)M + H]+), 373.1 (95, [(81Br)M +
H]+). 1H NMR (δ, ppm): 4.96 (s, 2 H, CH2), 5.02 (s, 2 H, CH2),
7.14–7.38 (m, 10 H, arom.), 8.50 (s, 1 H, H-6). 13C NMR
(δ, ppm): 45.1 (CH2), 52.1 (CH2), 94.5 (C-5), 127.3, 127.6, 127.7,
127.9, 128.4, 128.7 (arom. CHs), 136.3 (C-1′), 136.6 (C-1′), 144.2
(C-6), 150.6 (C-2), 158.8 (C-4). Elemental analysis calcd (%) for
C18H15BrN2O2 (371.228) C, 58.24; H, 4.07; Br, 21.52; N, 7.55,
found C, 58.03; H, 4.26; Br, 21.68; N, 7.71.
1-Benzyl-5-hydroxyuracil. 1-Benzyl-5-bromouracil has been
hydrolysed according to a published method.83 The crude
product was purified by column chromatography using the
solvent system 1 : 9 : 90 v/v% acetic acid/isopropanol/toluene to
aﬀord the title compound.
Mp.: 226–227 °C (sinters from 210 °C). ESI-MS (m/z): 219.1
(100, [M + H]+), 236.0 (10, [M + NH4]
+), 437.1 (25, [2M + H]+),
454.1 (31, [2M + NH4]
+), 672.2 (33, [3M + NH4]
+), 890.3 (5,
[4M + NH4]
+), 1326.7 (3, [12M + 2NH4]
2+), 1763.4 (4, [8M +
NH4]
+). 1H NMR (δ, ppm): 4.78 (s, 2 H, CH2), 7.19 (s, 1 H, H-6),
7.22–7.36 (m, 5 H, arom.), 8.66 (br. s, deuterable, 1 H, OH),
11.46 (br. s, deuterable, 1 H, NH). 13C NMR (δ, ppm): 49.9
(CH2), 124.6 (C-6), 127.5, 127.6, 128.7 (arom. CHs), 132.5 (C-5),
137.1 (C-1′), 149.6 (C-2), 160.9 (C-4). Elemental analysis calcd
(%) for C11H10N2O3 (218.209) C, 60.55; H, 4.62; N, 12.84, found
C, 60.34; H, 4.78; N, 12.71.
ESI-MS data of aggregates
The samples were prepared in the following way: a saturated
aqueous solution of solute, containing 100 mM solution of
NH4HCO3 (pH = 8) and methanol saturated with NH4HCO3
were mixed in a 1 : 99 ratio and the resulting diluted solutions
were used directly for the experiments. In some experiments
1-benzyl-5-hydroxyuracil has been dissolved in water or in
water containing 1,1,1,3,3,3-hexafluoroisopropanol (HFIP), in a
1 : 1 (v/v) ratio, or in neat HFIP. Analogously, for the experi-
ments with other complex-forming salts, aqueous solutions of
NaCl, KCl, Ca(NO3)2, Sr(NO3)2 and Ba(NO3)2 have been used
with an initial concentration of 100 mM each.
Conclusions
In the present work, we have investigated theoretically and
experimentally the quadruplex-forming ability of 5-substituted
uracil derivatives as analogues of 3-substituted xanthine
derivatives with a truncated imidazole ring. We showed com-
putationally that the recently suggested 5-aminouracil (n5U) is
not the most optimal building block for self-assembled tetra-
mers or quadruplex structures. Based on our careful quantum
chemical orbital analysis and EDA method we recommend a
new unit, expected to be more suitable: 5-hydroxyuracil (ho5U).
The self-assembly of the new candidate was corroborated by
ESI-MS experiments as well and we found that the new entity
provides encouraging cation-bound complexes either alone or
in combination with the 3-methylxanthine (X) unit.
Comparing the geometrical features of the ho5U-based and
X-based complexes, we encountered that the central cavity is
larger in the former case. This can open the way for further
investigations related to cation binding and cation mobility
properties along the central cavity channel. Nevertheless, our
calculations underlined that the new structures can bind
cations in this region as well.
Moreover, the relative positions of the backbone connection
points in the ho5U and X tetramers are almost the same,
which indicates that the new building block can be incorpor-
ated into quadruplex structures without any diﬃculty. Our
experimental and theoretical results convincingly demon-
strated the excellent self-assembly ability of ho5U. Therefore,
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the inclusion of the 5-hydroxyuracil moiety into mixed tetra-
meric or octameric structures with 3-substituted xanthines is
very promising.
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